The video investigates the impact of artificial intelligence (AI) on American healthcare, focusing on a government program called WISeR (Wasteful and Inappropriate Service Reduction) that uses AI to enforce prior authorization in traditional Medicare. This program, launched as a six-state pilot, requires AI companies to approve or deny certain medical procedures before they are performed. Patients like Michael Edgerly, who suffers from severe pain and mobility issues, have experienced significant delays and denials for necessary treatments, highlighting the program’s negative effects on patient care. Despite being intended to reduce wasteful spending, WISeR has led to thousands of denials, causing harm and frustration among patients and providers.
The companies behind WISeR’s AI systems are shrouded in secrecy, with complex corporate structures spanning multiple states and even India. The main company involved, Virtix Health, appears closely linked to CorroHealth, a firm specializing in revenue cycle management—essentially the administrative process of billing and insurance claims. CorroHealth’s business model involves maximizing billing codes and navigating insurance payments, sometimes bordering on aggressive tactics like upcoding, which inflates costs to Medicare. This reveals that AI’s current role in healthcare is less about improving patient outcomes and more about managing paperwork and financial disputes between providers and insurers.
The use of AI in this context has not demonstrated cost savings for the healthcare system. Instead, it may contribute to increased administrative burdens and inflated billing, a phenomenon insiders call “the bot wars,” where AI tools are used by both insurers and providers to push back and forth over payments. The companies involved, including Virtix and CorroHealth, generate significant revenue, with much of the work outsourced to cheaper labor markets abroad, such as India. Private equity firms like Patient Square Capital and the Carlyle Group control these companies, profiting from the system’s inefficiencies and the denial of patient care.
Despite concerns and mounting evidence of harm, the WISeR program has faced limited oversight and resistance in Congress. The Government Accountability Office criticized the program for bypassing congressional approval, and multiple bills have been introduced to end it. Over 60 members of Congress have called for its discontinuation, citing patient harm and lack of effectiveness. However, the administration plans to expand WISeR to cover more services and integrate AI more deeply into Medicare, raising questions about the motivations behind the program and its future impact on healthcare access.
Ultimately, the video highlights a troubling disconnect between the promise of AI in healthcare—such as improving diagnostics and personalized treatment—and its current application, which prioritizes cost control and administrative efficiency over patient well-being. Patients like Michael continue to suffer delays and denials, while AI companies and private equity investors profit. The story underscores the need for greater transparency, regulation, and a refocus on patient-centered care as AI becomes more embedded in the healthcare system.
Useful Links
